Table 1.
Protein expressed | Strain | Promoter | Substrate | Continuous strategy | Production kinetics | Optimization approach | References |
---|---|---|---|---|---|---|---|
Fab fragment (anti-HIV antibody 2F5) | X-33 | GAP | Glucose | Chemostat | Growth-coupled μ-saturated |
Optimized feeding from continuous data | Maurer et al., 2006 |
Fab fragment (anti-HIV antibody 3H6) | X-33 | GAP | Glucose | Chemostat | Growth-coupled μ-saturated |
Optimized feeding from continuous data | Buchetics et al., 2011 |
Fab fragment (anti-HIV antibody 2F5) | X-33 | GAP | Glucose | Chemostat | Growth-coupled | Optimal D at continuous mode | Garcia-Ortega et al., 2016 |
hGM-CSF (human) | GS115 Mut+ | GAP | Glucose | Chemostat | Linear | Fed-batch designed from continuous data | Khasa et al., 2007 |
phytase | X-33 | GAP | Glucose | Chemostat | Linear | Fed-batch designed from continuous data | Tang et al., 2010 |
srAFP | GS115 MutS | AOX | Glycerol/methanol | Chemostat | Growth-coupled | Fed-batch designed from continuous data | D'Anjou and Daugulis, 2001 |
°scFv | GS115 Mut+ | AOX | Methanol | DO-stat S-stat |
Bell shaped μ-saturated |
Trade-off between fed-batch and continuous | Yamawaki et al., 2007 |
hCTRB | GS115 Mut+ | AOX | Methanol | Nutriostat | Linear | Optimal D at continuous mode | Curvers et al., 2002 |
rHV2 | GS115 Mut+ | AOX | Methanol | Chemostat | Bell shaped | Fed-batch designed from continuous data | Zhou and Zhang, 2002 |
Porcine trypsinogen | X-33 | AOX | Glucose/methanol | Chemostat | Bell shaped | Optimal D at continuous mode | Paulová et al., 2012 |
Avidin | GS115 Mut+ | AOX | Methanol/glycerol/ sorbitol | Chemostat | Linear | Fed-batch designed from continuous data | Jungo et al., 2006, 2007a,c |
CalB | X-33 | PGK | Glycerol | Chemostat | Linear | Trade-off between fed-batch and continuous | de Macedo Robert et al., 2019 |
Serum albumin (human) | X-33 | THI11 | Glucose | Chemostat | Growth-coupled | Optimized feeding from continuous data | Landes et al., 2016 |